Health Catalyst, Inc Common Stock (HCAT) is a publicly traded Healthcare sector company. As of August 7, 2026, HCAT trades at $1.69 with a market cap of $176.61M and a P/E ratio of -0.60. HCAT moved -26.88% today. Year to date, HCAT is +1.32%; over the trailing twelve months it is -39.53%. Its 52-week range spans $0.96 to $8.00. Analyst consensus is neutral with an average price target of $2.29. Rallies surfaces HCAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for HCAT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $1.69 |
| Market Cap | $176.61M |
| P/E Ratio | -0.60 |
| EPS | $-3.74 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.00 |
| 52-Week Low | $0.96 |
| Volume | 13.05K |
| Avg Volume | 0 |
| Revenue (TTM) | $302.48M |
| Net Income | $-265.26M |
| Gross Margin | 0.00% |
9 analysts cover HCAT: 0 strong buy, 2 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $2.29.